相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Frequent Hypoglycemia Among Elderly Patients With Poor Glycemic Control
Medha N. Munshi et al.
ARCHIVES OF INTERNAL MEDICINE (2011)
Efficacy of A1C Reduction Using Internet Intervention in Patients with Type 2 Diabetes Treated with Insulin
Hugh D. Tildesley et al.
CANADIAN JOURNAL OF DIABETES (2011)
Insulin treatment for type 2 diabetes: When to start, which to use
Marwan Hamaty
CLEVELAND CLINIC JOURNAL OF MEDICINE (2011)
The Effect of Liraglutide Added to U-500 Insulin in Patients with Type 2 Diabetes and High Insulin Requirements
Wendy Lane et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2011)
Participants' experiences of intensifying insulin therapy during the Treating to Target in Type 2 Diabetes (4-T) trial: qualitative interview study
N. Jenkins et al.
DIABETIC MEDICINE (2011)
The importance of glycemic control: how low should we go with HbA1c? Start early, go safe, go low
Katrien Benhalima et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2011)
Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: A meta-analysis
Chun-Yu Zhang et al.
ANNALS OF MEDICINE (2010)
Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada
Manoela F. B. Braga et al.
CANADIAN JOURNAL OF CARDIOLOGY (2010)
Effects of Intensive Glucose Lowering in the Management of Patients With Type 2 Diabetes Mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
Matthew C. Riddle
CIRCULATION (2010)
Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization
Catherine E. Cooke et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Effect of Internet Therapeutic Intervention on A1C Levels in Patients With Type 2 Diabetes Treated With Insulin
Hugh D. Tildesley et al.
DIABETES CARE (2010)
Counterpoint: Intensive Glucose Control and Mortality in ACCORD-Still Looking for Clues
Matthew C. Riddle
DIABETES CARE (2010)
Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial
Matthew C. Riddle et al.
DIABETES CARE (2010)
Correlates of Insulin Injection Omission
Mark Peyrot et al.
DIABETES CARE (2010)
Differences between long-acting insulins for the treatment of type 2 diabetes
Michael Gejl et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Primary Non-adherence to Prescribed Medications
Andrew J. Karter et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2010)
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
Faramarz Ismail-Beigi et al.
LANCET (2010)
The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study
Michael E. Miller et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study
Michael E. Miller et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Improving Patient Acceptance and Adherence in Diabetes Management: a Focus on Insulin Therapy
Robert E. Rakel
ADVANCES IN THERAPY (2009)
Glycemic Control in Type 2 Diabetes: Time for an Evidence-Based About-Face?
Victor M. Montori et al.
ANNALS OF INTERNAL MEDICINE (2009)
Barriers to Insulin Injection Therapy Patient and Health Care Provider Perspectives
Richard R. Rubin et al.
DIABETES EDUCATOR (2009)
Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: Overview and metaanalysis of five trials
Ivan Tkáč
DIABETES RESEARCH AND CLINICAL PRACTICE (2009)
Intensive glucose control and macrovascular outcomes in type 2 diabetes
F. M. Turnbull et al.
DIABETOLOGIA (2009)
Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control
S. Akalin et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
Kausik K. Ray et al.
LANCET (2009)
Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Measuring psychological insulin resistance - Barriers to insulin use
Mary E. Larkin et al.
DIABETES EDUCATOR (2008)
Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management(RECAP-DM) Study
F. Alvarez Guisasola et al.
DIABETES OBESITY & METABOLISM (2008)
Paget's disease of the mandible
Mayank B. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Refill adherence of antihyperglycaemic drugs related to glucose control (HbA1c) in patients with type 2 diabetes
Lena Kindmalm et al.
ACTA DIABETOLOGICA (2007)
Insulin-associated weight gain in diabetes - causes, effects and coping strategies
David Russell-Jones et al.
DIABETES OBESITY & METABOLISM (2007)
The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes -: results of the randomized, controlled PREDICTIVE™ 303 study
L. Meneghini et al.
DIABETES OBESITY & METABOLISM (2007)
Glycemia treatment strategies in the action to control cardiovascular risk in diabetes (ACCORD) trial
Hertzel C. Gerstein et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
High frequency of unrecognised hypoglycaemias in patients with type 2 diabetes is discovered by continuous glucose monitoring
K. K. Weber et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2007)
A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study
H. C. Gerstein et al.
DIABETIC MEDICINE (2006)
Resistance to insulin therapy among patients and providers - Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study
M Peyrot et al.
DIABETES CARE (2005)
Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study)
SB Harris et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: A population-based study
LA Donnelly et al.
DIABETIC MEDICINE (2005)
Addressing dosing frequency in diabetes: A simple approach to improving adherence to therapy and clinical outcomes
AD Morris
DIABETES EDUCATOR (2003)
The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control
A Chico et al.
DIABETES CARE (2003)
The treat-to-target trial - Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
MC Riddle et al.
DIABETES CARE (2003)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude
TM Wallace et al.
QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS (2000)
分享论文
